BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17120593)

  • 21. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.
    Andrade RM; Alarcón GS; Fernández M; Apte M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2007 Feb; 56(2):622-30. PubMed ID: 17265497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
    Hiraki LT; Feldman CH; Liu J; Alarcón GS; Fischer MA; Winkelmayer WC; Costenbader KH
    Arthritis Rheum; 2012 Aug; 64(8):2669-76. PubMed ID: 22847366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
    Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
    Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices.
    Szilagyi PG; Schaffer S; Shone L; Barth R; Humiston SG; Sandler M; Rodewald LE
    Pediatrics; 2002 Nov; 110(5):e58. PubMed ID: 12415064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
    Alarcón GS; McGwin G; Bartolucci AA; Roseman J; Lisse J; Fessler BJ; Bastian HM; Friedman AW; Reveille JD;
    Arthritis Rheum; 2001 Dec; 44(12):2797-806. PubMed ID: 11762940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus.
    Scalzi LV; Hollenbeak CS; Wang L
    Arthritis Rheum; 2010 Sep; 62(9):2767-75. PubMed ID: 20506536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.
    Danila MI; Pons-Estel GJ; Zhang J; Vilá LM; Reveille JD; Alarcón GS
    Rheumatology (Oxford); 2009 May; 48(5):542-5. PubMed ID: 19233884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility.
    Lee YH; Ota F; Kim-Howard X; Kaufman KM; Nath SK
    Rheumatology (Oxford); 2007 Aug; 46(8):1274-6. PubMed ID: 17569747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).
    Burgos PI; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    Rheumatology (Oxford); 2010 Sep; 49(9):1720-5. PubMed ID: 20498010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?
    Uribe AG; McGwin G; Reveille JD; Alarcón GS
    Autoimmun Rev; 2004 Jun; 3(4):321-9. PubMed ID: 15246029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
    Calvo-Alén J; McGwin G; Toloza S; Fernández M; Roseman JM; Bastian HM; Cepeda EJ; González EB; Baethge BA; Fessler BJ; Vilá LM; Reveille JD; Alarcón GS;
    Ann Rheum Dis; 2006 Jun; 65(6):785-90. PubMed ID: 16269429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture.
    Reveille JD; Moulds JM; Ahn C; Friedman AW; Baethge B; Roseman J; Straaton KV; Alarcón GS
    Arthritis Rheum; 1998 Jul; 41(7):1161-72. PubMed ID: 9663471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent racial trends in mortality from systemic lupus erythematosus.
    Walsh SJ; Algert C; Gregorio DI; Reisine ST; Rothfield NF
    J Rheumatol; 1995 Sep; 22(9):1663-8. PubMed ID: 8523342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial aspects of comorbidity in systemic lupus erythematosus.
    Walsh SJ; Algert C; Rothfield NF
    Arthritis Care Res; 1996 Dec; 9(6):509-16. PubMed ID: 9136295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
    Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
    Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels.
    Ward MM
    Arthritis Rheum; 2004 Aug; 51(4):616-24. PubMed ID: 15334436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients.
    Calvo-Alén J; Toloza SM; Fernández M; Bastian HM; Fessler BJ; Roseman JM; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
    Arthritis Rheum; 2005 Jul; 52(7):2060-8. PubMed ID: 15986376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture.
    Alarcón GS; Roseman J; Bartolucci AA; Friedman AW; Moulds JM; Goel N; Straaton KV; Reveille JD
    Arthritis Rheum; 1998 Jul; 41(7):1173-80. PubMed ID: 9663472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement.
    Alarcón GS; Bastian HM; Beasley TM; Roseman JM; Tan FK; Fessler BJ; Vilá LM; McGwin G;
    Lupus; 2006; 15(1):26-31. PubMed ID: 16482742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.